Real-world study shows HPV genotyping refines risk stratification in HPV-positive women, suggesting conservative management is suitable for non-16/18 high-risk HPV infections.
The benefits and harms of managing women based on HPV positivity and cytology results can be better balanced by inclusion of HPV genotyping in screening and choosing more conservative management for other high-risk HPV compared to HPV16/18.
No takes yet. Share an insight, caveat, or question.
Hashim et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: